Want to join the conversation?
$PRGO's adjusted net sales for 1Q16 grew by 33% to $1.34Bil on a constant currency basis from last year. This increase is attributable primarily to $318MM related to the inclusion of the BCH segment and 2% growth in the CHC segment on a constant currency basis, excluding net sales from VMS.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.